Primary Device ID | 03573026615178 |
NIH Device Record Key | da306cd2-cb7f-4c6d-a4ac-c4e5bf81a91e |
Commercial Distribution Status | In Commercial Distribution |
Brand Name | PREVI® COLOR DUAL SAMPLE CHAMBERS FAST (WHITE) |
Version Model Number | PREVI® COLOR DUAL SAMPLE CHAMBERS FAST (WHITE) |
Company DUNS | 276816717 |
Company Name | BIOMERIEUX SA |
Device Count | 48 |
DM Exempt | false |
Pre-market Exempt | true |
MRI Safety Status | Labeling does not contain MRI Safety Information |
Human Cell/Tissue Product | false |
Device Kit | false |
Device Combination Product | false |
Single Use | true |
Lot Batch | true |
Serial Number | false |
Manufacturing Date | false |
Expiration Date | true |
Donation Id Number | false |
Contains Natural Rubber Latex | false |
Labeled No Natural Rubber Latex | false |
RX Perscription | true |
OTC Over-The-Counter | false |
Device Issuing Agency | Device ID |
---|---|
GS1 | 03573026227722 [Primary] |
GS1 | 03573026615178 [Unit of Use] |
KPA | Slide stainer, automated |
Steralize Prior To Use | false |
Device Is Sterile | false |
Public Version Status | New |
Device Record Status | Published |
Public Version Number | 1 |
Public Version Date | 2020-08-24 |
Device Publish Date | 2020-08-14 |
03573026256685 - ETEST® Gentamicin (GM) | 2024-04-15 Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 1 |
03573026376604 - ETEST® Amoxicillin (AC) | 2024-04-15 Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 1 |
03573026377731 - ETEST® Flucytosine (FC) | 2024-04-15 Etest is a quantitative technique for determining susceptibility of antifungal. It provides a gradient of 15 doubling dilutions |
03573026560690 - ETEST® Meropenem/Vaborbactam (MEV) | 2024-04-15 ETEST® is a manual, quantitative technique for determination of antimicrobial susceptibility of non-fastidious Gram-negative an |
03573026475352 - ETEST® Telavancin (TLA) | 2024-04-12 Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 1 |
03573026252526 - ETEST® Cefepime (PM) | 2024-04-08 Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 1 |
03573026253219 - Etest® TIC/CLAV-CON2 | 2024-04-08 Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 1 |
03573026617851 - VITEK®MS | 2024-03-18 VITEK MS ready to use reagent for calibration and fine tuning of the VITEK MS instrument |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
PREVI 79063724 3987824 Live/Registered |
bioMérieux 2008-07-02 |
PREVI 77397807 not registered Dead/Abandoned |
bioMérieux, Inc. 2008-02-15 |
PREVI 77049972 not registered Dead/Abandoned |
HerbalScience Singapore Pte Ltd 2006-11-22 |